SCHEMBL191141

SCHEMBL191141

Clc1cc(Sc2ccccc2)ccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.47
GRM5 P41594 2/20 0.46
TDP1 Q9NUW8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
DDAH1 O94760 1/20 0.39
NOS1 P29475 1/20 0.39
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
RECQL P46063 1/20 0.38
LOX P28300 1/20 0.38
LOXL3 P58215 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
HTR2C P28335 1/20 0.38
HTR6 P50406 1/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL190886 0.85 ALDH1A1 (0.53) GRM5L3MBTL1LMNAKDM4EALDH1A1
SCHEMBL191183 0.84 L3MBTL1 (0.47) GRM5DDAH1NOS1MAOAMAOB
SCHEMBL1460674 0.81 MAPT (0.54) GRM5ADORA2AADORA1DDAH1NOS1
SCHEMBL192475 0.79 L3MBTL1 (0.61) TRPA1GRM5TDP1L3MBTL1SMN1; SMN2
SCHEMBL191204 0.79 HPGD (0.44) TRPA1GRM5TDP1L3MBTL1LMNA
SCHEMBL190876 0.78 PTGIR (0.45) ALDH1A1MEN1KMT2AIDO1
SCHEMBL17397891 0.77 LMNA (0.44) MAOAMAOBL3MBTL1HTR2CHTR6
SCHEMBL191123 0.77 AR (0.41) TRPA1GRM5TDP1RECQLHTR2C
SCHEMBL11478259 0.76 NOS1 (0.42) GRM5DDAH1NOS1MAOAMAOB
SCHEMBL190418 0.76 PKM (0.49) TDP1LMNASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1986645-B1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC (US) 2012-01-04 EP disclosed
US-8022222-B2 Glucokinase activators ARRAY BIOPHARMA, INC. (US) 2011-09-20 US disclosed
US-20090247526-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2009-10-01 US disclosed
EP-1986645-A1 GLUCOKINASE ACTIVATORS Array Biopharma, Inc. (US) 2008-11-05 EP disclosed
WO-2007089512-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247526-A1 GLUCOKINASE ACTIVATORS GCKR, GCK, GALK1 TRPA1 4846/4885GRM5 1123/4885TDP1 2864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.